Modeling the CD4 decline in HIV with Low Cost Predictors for
T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers
7
Single amino acid change in gp41 region of HIV 1 alters bystander apoptosis and CD4 decline in humanized mice
13
Immune correlates of CD4 decline in HIV infected patients experiencing virologic failure before undergoing treatment interruption
7
Modeling the CD4 decline in HIV with Low Cost Predictors for Effective HIV Management in Resource Poor Settings
135
TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients
13
Association of APOBEC3G genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiency
6
Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings
11
Cost of noninfectious comorbidities in patients with HIV
8
Challenges in Managing Hospitalized HIV Infected Persons with Low Absolute CD4 and Preserved CD4 Percentage
8
Predictors of CD4 Count in HIV Infected Patients
83
The Difference of CD4 Count Between HIV Positive Patients With Cognitive Decline and Without Cognitive Decline
10
Immunological predictors of CD4+T cell decline in antiretroviral treatment interruptions
6
Performance decline in low-stakes educational assessments: different mixture modeling approaches
25
Low Cost Printer for DLP Stereolithography
8
Reproductive health options among HIV-infected persons in the low-income Niger Delta of Nigeria
7
Greater Expansion of IFN γ﹣ CD4+ NKT Cells in HIV 1 Compared with HIV 2 Infected Subjects with Preserved CD4+ T Cell Counts
6
Predictors of disease progression in HIV infection: a review
14
Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment
10
HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study
13
<p>Prevalence and Predictors of CD4+ T-Lymphocytopenia Among HIV-Negative Tuberculosis Patients in Uganda</p>
7